The NurseApproved evaluation process requires products to meet stringent criteria, including clinical safety, workflow integration, and ease of use. Dama Assist, designed specifically to address the fragmentation in women’s hormone therapy, surpassed these benchmarks by centralizing research databases and drug references into a single interface. Reviewers noted that the platform’s focus on this specialized area provides a depth of information currently missing from broader, general-purpose medical tools.

Elena Rueda, CEO and founder of Dama Health, stated that the certification validates the company's decision to concentrate on a single, historically underserved medical specialty. Rebecca Love, CEO of NurseApproved, emphasized that the seal is strictly merit-based and cannot be purchased, serving as a signal to healthcare systems that the technology has been vetted by the clinicians who manage patient care at the bedside. The platform currently integrates data on over 900 FDA-approved medications to assist providers in hormone therapy prescribing.